Clin2
NCT06966362Possibly a fitNot yet recruiting

Varenicline to help veterans reduce smoking

VeteransTobacco Use DisorderCigarette SmokingTobacco Dependence

Part of Mental health clinical trials.

This trial tests a medicine called varenicline to help veterans who aren't ready to quit smoking but want to cut down. It may help reduce the number of cigarettes you smoke each day.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
400 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You smoke at least 5 cigarettes a day and have for the past 6 months
  • You are a veteran
  • You are at least 21 years old
  • You are not ready to quit within the next 30 days but want to cut down
  • You can read, write, and speak English
  • If you are female, you must use birth control while taking the study medicine

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07714200Not yet recruiting
Smoking quit help for veterans experiencing homelessness

This study tests a program to help veterans who are homeless quit smoking by offering rewards for staying tobacco-free. It aims to see if this approach helps more veterans quit than standard support.

Durham, North Carolina
NCT06883162Recruiting· Phase 3
A study to help people stop smoking tobacco and reduce cannabis use

This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.

Charleston, South Carolina
NCT06688539Recruiting· Phase 4
Quitting e-cigarettes in adults who also use cannabis

This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.

Charleston, South Carolina
NCT06582888Recruiting· Early Phase 1
VR attention test for smoking cravings

This study tests whether a virtual reality (VR) program can measure how your brain pays attention to smoking cues. It also involves taking a medication called varenicline (Chantix) to see if it reduces cravings. You may be eligible if you are a daily smoker, have been smoking for at least 3 years, and are not ready to quit in the next month.

San Diego, California
NCT07040566Recruiting· Phase 2
Varenicline to help stop vaping

This trial tests whether varenicline, a medicine that reduces cravings, can help people quit using e-cigarettes that contain nicotine. You must be a daily nicotine vaper and live in Connecticut or South Carolina.

New Haven, Connecticut
NCT03495024Recruiting· Phase 4
Varenicline for quitting smoking in people with schizophrenia

This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.

Philadelphia, Pennsylvania

Hear when a new Tobacco Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.